Ramy Ammar, Ph.D. has more than 17 years of experience in academic and industrial R&D settings. He is an Assistant Professor of Pharmacology, graduated from faculty of Pharmacy, and has received his Ph.D. in Pharmacology from University of Bonn, Germany in 2014. He trained during his postdoc position at the faculty of Pharmacy, Bonn University, on physiologically based pharmacokinetics modelling and simulation to enrich his wet lab experience with dry lab tools. His research interests are related to the endocannabinoid system, disorders of gut-brain interaction, gut microbiome, phytomedicine, and novel alternative approaches for reducing animal use in pharmacology and toxicology with a track record of publications and conference presentations in these fields. He is currently part of the global R&D organization within Bayer Consumer health working as an Emerging science and Innovation Director leading the transformational innovation for the Digestive Health category.
